Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

Peptomyc: the quest for a ‘universal’ cancer treatment

Start-up company Peptomyc is looking to develop a ‘universal cancer treatment’, which inhibits an oncoprotein called Myc that is integral to the mechanism of cancer cells. The company has described their its strategy as ‘the opposite of personalised medicine’ – so could it work? Abi Millar reports.

Close
Close
Close

Go Top